Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Neuhaus

Showing results (741-750 of 830) with videos related to

Pageof 83
Sort By:
Transplantation Proceedings|December 1, 1996
Long-term follow-up in hepatitis C patients with respect to immunosuppressionA R Mueller, K P Platz, T Berg, et al.
Transplantation|June 1, 1993
Comparison of quadruple immunosuppression after liver transplantation with ATG or IL-2 receptor antibodyP Neuhaus, W O Bechstein, G Blumhardt, et al.
Transplantation Proceedings|December 1, 1996
Does the choice of primary immunosuppression influence the prevalence of cardiovascular risk factors after liver transplantation?O Guckelberger, J M Langrehr, W O Bechstein, et al.
Transplantation Proceedings|March 20, 1999
Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantationJ Klupp, M Glanemann, W O Bechstein, et al.
Transplantation Proceedings|March 20, 1999
Contribution of donor age and ischemic injury in chronic renal allograft dysfunctionS G Tullius, A Reutzel-Selke, M Nieminen-Kelhä, et al.
Transplantation|October 27, 1996
A new oral formulation of cyclosporine for early oral immunosuppressive therapy in liver transplant recipientsM Winkler, G Haller, K Oldhafer, et al.
Transplantation|July 15, 1997
Chronically rejected rat kidney allografts induce donor-specific toleranceS G Tullius, M Nieminen, W O Bechstein, et al.
Transplantation Proceedings|March 27, 2001
Mycophenolate mofetil is superior in combination with tacrolimus compared to cyclosporine for immunosuppressive therapy after liver transplantationM Glanemann, J Klupp, J M Langrehr, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 6, 2009
Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' studyJ M Neuberger, R D Mamelok, P Neuhaus, et al.
Transplantation Proceedings|February 1, 1997
Distribution of lymphocyte subtypes in liver transplant recipientsN Rayes, W O Bechstein, H P Volk, et al.
Pageof 83

Showing results (741-750 of 830) with videos related to

Sort By:
Pageof 83
Transplantation Proceedings|December 1, 1996
Long-term follow-up in hepatitis C patients with respect to immunosuppressionA R Mueller, K P Platz, T Berg, et al.
Transplantation|June 1, 1993
Comparison of quadruple immunosuppression after liver transplantation with ATG or IL-2 receptor antibodyP Neuhaus, W O Bechstein, G Blumhardt, et al.
Transplantation Proceedings|December 1, 1996
Does the choice of primary immunosuppression influence the prevalence of cardiovascular risk factors after liver transplantation?O Guckelberger, J M Langrehr, W O Bechstein, et al.
Transplantation Proceedings|March 20, 1999
Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantationJ Klupp, M Glanemann, W O Bechstein, et al.
Transplantation Proceedings|March 20, 1999
Contribution of donor age and ischemic injury in chronic renal allograft dysfunctionS G Tullius, A Reutzel-Selke, M Nieminen-Kelhä, et al.
Transplantation|October 27, 1996
A new oral formulation of cyclosporine for early oral immunosuppressive therapy in liver transplant recipientsM Winkler, G Haller, K Oldhafer, et al.
Transplantation|July 15, 1997
Chronically rejected rat kidney allografts induce donor-specific toleranceS G Tullius, M Nieminen, W O Bechstein, et al.
Transplantation Proceedings|March 27, 2001
Mycophenolate mofetil is superior in combination with tacrolimus compared to cyclosporine for immunosuppressive therapy after liver transplantationM Glanemann, J Klupp, J M Langrehr, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 6, 2009
Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' studyJ M Neuberger, R D Mamelok, P Neuhaus, et al.
Transplantation Proceedings|February 1, 1997
Distribution of lymphocyte subtypes in liver transplant recipientsN Rayes, W O Bechstein, H P Volk, et al.
Pageof 83